Great Point Partners has completed a dividend recap of Health Systems International, according to a Dec. 27 statement. Great Point, a Greenwich, Conn.-based PE firm, did not disclose financial terms of the dividend recap. However, Great Point said that the transaction was an “attractive opportunity” for HSI’s shareholders, which include company management and GPP’s LPs. Indianapolis-based Health Systems provides outsourced medical cost management services for self-insured corporations and insurance companies.

Streamline Health Solutions, a provider of enterprise content management and business analytics solutions for healthcare organizations, has acquired New York City-based Meta Health Technology. The business is a provider of health information management solutions across the U.S. and Canada. In a separate transaction, the company completed a $12 million equity investment led by Great Point [...]

Great Point Partners has sold Caprion Proteomics to Chicago Growth Partners. Financial terms weren’t announced. Caprion provides proteomics services to pharmaceutical and biotechnology companies. News of the deal was announced by Harris Williams which advised Caprion. PRESS RELEASE Harris Williams & Co., a preeminent middle market investment bank focused on the advisory needs of clients [...]

WaferGen Biosystems Inc., a startup focusing on genomic analysis, has added Scott Davidson and Joseph Pesce to its board. Davidson currently serves as managing director at Great Point Partners, where he focuses on medical devices and diagnostics investing. Pesce is a managing director and operating partner of Great Point Partners.

Great Point Partners, a Greenwich, Conn.-based firm focused on the healthcare investments, has put an undisclosed amount into Aris Teleradiology. Hudson, Ohio-based Aris was formed in 2007 and provides radiology services to hospitals, imaging centers, and radiology groups. Terms of the deal were not released.

MidCap Financial a commercial finance company focused on middle market healthcare companies, has acted as sole bookrunner, lead arranger, documentation agent and administrative agent in a senior secured credit facility in support of a leveraged recapitalization and growth equity investment in Professional Orthopedic and Sport Physical Therapy by Great Point Partners. GPP, based in Greenwich, [...]

Cytovance Biologics has closed on $22.5 million in growth capital from Greenwich, Conn.-based firm Great Point Partners. Cytovance, which is based in Oklahoma City, is a manufacturer of mammalian and microbial biologics for biotechnology and pharmaceutical customers. The new funding will help Cytovance to expand its manufacturing operations. As a result of the round, Great Point managing directors Jeffrey Jay and David Kroin, as well as senior vice president Noah Rhodes, will join Cytovance’s board.